Procurement and Pricing of New Vaccines for Developing Countries
Several vaccines that have come to market, including the rotavirus, pneumococcal conjugate, and human papillomavirus vaccines, have the potential to bring large public health benefits to developing countries. This eight-page policy brief explains how these vaccines and others are purchased for the public sector in developing countries, with a focus on the roles of the United Nations Children's Fund (UNICEF) and the Pan American Health Organization, as well as the GAVI Alliance, which is the major source of vaccine financing for the poorest countries and works closely with UNICEF. The brief describes the procurement process during which vaccine prices emerge and reviews data on vaccine prices in industrialized and developing countries.
Author(s): International AIDS Vaccine Initiative
Download file (English)
166 KB PDF (Located at www.iavi.org)